These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 1198438)

  • 1. Proceedings: Prothrombin activation.
    Greenberg J; Goldstein R
    Thromb Diath Haemorrh; 1975 Nov; 34(2):562. PubMed ID: 1198438
    [No Abstract]   [Full Text] [Related]  

  • 2. The conversion of prothrombin to thrombin. III. The factor Xa-catalyzed activation of prothrombin.
    Esmon CT; Jackson CM
    J Biol Chem; 1974 Dec; 249(24):7782-90. PubMed ID: 4430674
    [No Abstract]   [Full Text] [Related]  

  • 3. The conversion of prothrombin to thrombin. V. The activation of prothrombin by factor Xa in the presence of phospholipid.
    Esmon CT; Owen WG; Jackson CM
    J Biol Chem; 1974 Dec; 249(24):7798-807. PubMed ID: 4430675
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the conversion mechanism of prothrombin into thrombin.
    Okabe H
    Tohoku J Exp Med; 1974 Nov; 114(3):215-25. PubMed ID: 4456684
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin.
    Thompson EA; Salem HH
    J Clin Invest; 1986 Jul; 78(1):13-7. PubMed ID: 3013935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of intrinsic prothrombin activation by fibrinogen and fibrin I.
    Okwusidi JI; Anvari N; Ofosu FA
    J Lab Clin Med; 1993 Jan; 121(1):64-70. PubMed ID: 8426082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of prothrombin Barcelona. Evidence for active high molecular weight intermediates.
    Rabiet MJ; Elion J; Benarous R; Labie D; Josso F
    Biochim Biophys Acta; 1979 Apr; 584(1):66-75. PubMed ID: 444582
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor X.
    Jackson CM
    Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Isolation and properties of the abnormal factor X induced by vitamin K antagonist (PIVKA-X).
    Lindhout MJ; Kop-Klaassen BH
    Thromb Diath Haemorrh; 1975 Nov; 34(2):592. PubMed ID: 1239095
    [No Abstract]   [Full Text] [Related]  

  • 12. Self-damping mechanism in blood coagulation.
    Nemerson Y; Silverberg SA; Jesty J
    Thromb Diath Haemorrh; 1974 Sep; 32(1):57-64. PubMed ID: 4454045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of thrombin and autoprothrombin C (F-X a ) as a mutual depletion system.
    Dombrose FA; Seegers WH; Sedensky JA
    Thromb Diath Haemorrh; 1971 Aug; 26(1):103-23. PubMed ID: 5112369
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the activation of bovine prothrombin. Isolation and characterization of the fragments released from the prothrombin by activated factor X.
    Morita T; Nishibe H; Iwanaga S; Suzuki T
    J Biochem; 1974 Nov; 76(5):1031-48. PubMed ID: 4476731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interactions of blood coagulation factors (author's transl)].
    Cierniewski CS; Krajewski T
    Postepy Biochem; 1981; 27(1):81-105. PubMed ID: 6792614
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
    Suzuki K
    Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation pathways of the coagulation system in normal haemostasis.
    Osterud B
    Scand J Haematol; 1984 Apr; 32(4):337-45. PubMed ID: 6372076
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelets and coagulation proteins.
    Walsh PN
    Fed Proc; 1981 May; 40(7):2086-91. PubMed ID: 6785110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.